Biography


Prof. Gary Walsh is Chair of Industrial Biotechnology at the University of Limerick, Ireland. He obtained BSc & PhD degrees from the National University of Ireland at Galway in 1986 and 1989, respectively and more recently a graduate diploma in academic practice from UL in 2009. Prior to joining the university in 1994 he held the following industrial positions: Senior research scientist, Alltech Ireland Ltd., Production manager, Bioniche pharmaceuticals, Research scientist, Olympus diagnostics.

His research and scholarship interests span enzyme and pharmaceutical biotechnology as well as curriculum design and he was the recipient of the university's special achievement in research award in 2006.

His 106 ‘class 1' publications include: 9 authored books, 2 edited books, 17 book chapters and 78 journal articles. In addition he has authored 94 refereed conference proceedings, 5 book reviews and 7 reports. Three of his books are international student biotechnology textbooks that have gone to second edition and for which Chinese and Japanese foreign language editions have been published.

He has participated in research grant proposal applications which have successfully secured €3.1 million in funding, of which his personal share is €1.7 million. He has supervised/continues to supervise 22 researchers (14 postgraduate & 8 post-doctoral). He has served as a research proposal evaluator for various scientific funding bodies in Ireland, Holland, Norway and the UK.

He has presented his work at 60 international conferences, which include 33 guest/keynote presentations. He has served as session/conference chairman at 6 international conferences and as a member of the scientific advisory panel for 12 international conferences conferences.

He has acted as external examiner for 13 PhD and 4 MSc research theses in various Irish institutions, as well for Monash university in Australia. He has/continues to serve as external examiner for undergraduate taught programs in 4 Irish Institutes of Technology and 2 Irish Universities.

He teaches various biotechnology modules in Limerick and was the recipient of the university's excellence in teaching award in 2003. He has served as course director, B.Sc. industrial biochemistry for 2 terms and as the University's (acting) dean, teaching & learning from August to December 2004. He has lectured on taught courses at the University of Grenoble, France, the University of Jyvaskla, Finland and the National University of Ireland at Galway.

He chaired the University of Limerick institutional committee preparing for the 2012 institutional quality review and was the main author of the associated Institutional Self Assessment Report.

He has served as (founding) editor, biotechnology section, of the European Journal of Pharmaceutics and Biopharmaceutics and as a member of the editorial boards of Biopharm. International, New Drugs and the Encyclopaedia of Industrial Biotechnology. He has also served as scientific secretary and as a member of the board of governors of the European Association of Pharmaceutical Biotechnology and is a former Fulbright research visiting professor at the University of Georgia, in the United States.

Research Interests

Enzyme biotechnology: The development of renewable sources of liquid fuels as an alternative to fossil fuels is receiving increasing global attention due environmental, economic and energy security concerns. The production of bioethanol from cellulose-based raw materials (e.g. grass, straw & wood) is at the forefront of this technology, but a major stumbling block is how to effectively degrade the cellulose to its glucose building blocks (the glucose is then fermented to ethanol, basically by brewing technology). A major ongoing focus of my research group is the identification and use of enzymes (proteins that speed up chemical reactions) derived from thermoacidophilic bacteria (bugs that grow best in boiling acid) to more efficiently achieve cellulose degradation (a process that currently usually entails the use of boiling acid). These enzymes are also academically interesting because they work best under such extreme conditions. An additional focus of my research group is to identify selected enzymes produced by acidophilic bugs which can be used as digestive supplements in humans or animals (working in the acidic environs of the stomach). For example, the identification of acid-active ‘lactase' enzymes to degrade milk lactose in the stomach, thereby alleviating lactose intolerance (which effects up to 75% of the world's adult population).

Pharmaceutical biotechnology (Biopharmaceuticals): Biopharmaceuticals are drugs (mainly proteins such as insulin and antibodies, but also pieces of DNA called ‘gene therapy' products) that are synthesized biologically (as opposed to chemically), usually via genetic engineering. These products are at the cutting edge of the pharmaceutical sector, recording sales of €107 billion in 2011. My research in this area focuses largely upon altering the method of manufacturing (bioprocessing) of these products in order to achieve manufacturing more economically and making it more environmentally friendly in the process (green pharmaceutical manufacturing) We also work on stabilizing such proteins by attaching a chemical called PEG to them, as well as on the identification & analysis of trends/ likely future directions in biopharmaceutical production systems/ products/regulatory science.

Curriculum design.
Curriculum design and development, particularly with reference to pharmaceutical biotechnology/ protein biotechnology.

Professional Activities

Education

  • 2009 University of Limerick - Graduate Diploma in Academic Practice
  • 1989 University College Galway - Ph.D.
  • 1986 University College Galway - B.Sc.

Award

  • 2006 - Special achievement in research award
  • 2003 - University of Limerick excellence in teaching award

Committee

  • 2004 International advisory committee, Pharma BioTec Europe 2004 conference,
  • 2002 Board of governors and executive committee, European Association of Pharma Biotechnology,
  • 2002 Scientific secretary, European Association of Pharma Biotechnology,

Employment

  • 1994 CES dept, UL. - Assistant lecturer
  • 1992 Alltech European Biosciences Research Centre - Senior research scientist
  • 1990 Vetrepharm Ireland - Production manager
  • 1989 Olympus diagnostics, Tulla. - Research scientist

Publications

Peer Reviewed Journals

1994

Recombinant reproduction

DeKoning, W., Walsh, G., Wrenn, A., and Headon, D. (1994) Recombinant reproduction. Nature Biotechnology :988-992

Books

Book Chapters

Edited Books

This author has not written any publications of this type yet.

Other Journals

This author has not written any publications of this type yet.

Conference Publications

2010

Environ 2010

Witt, M. O'Dwyer, T. and Walsh, G. (2010) Environ 2010.

2009

Environ 2009

Cliffe, F., Walsh, G. and O'Dwyer, T. (2009) Environ 2009.

2009

Environ 2009

Robinson, C. , Walsh, G. and O'Dwyer, T. (2009) Environ 2009.

Conference Contributions

This author has not written any publications of this type yet.

Published Reports

This author has not written any publications of this type yet.

Editorials

This author has not written any publications of this type yet.

Book Reviews

This author has not written any publications of this type yet.

Other Publications

This author has not written any publications of this type yet.